Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Neurodegenerative Disease Research. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel InX3-catalyzed aqueous synthesis of bis-indolylmethanes. High purity, green process for Alzheimer's drug intermediates. Cost-effective manufacturing solution.
Patent CN111393419B reveals a catalyst-free radical cyclization method for ether-substituted 2-pyrrolidones, offering high atom economy and simplified manufacturing for pharmaceutical intermediates.
Patent CN116621810A reveals a stable synthesis route for 2-methyl nicotine. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel acid-catalyzed cyclization for fused biindoles. Mild conditions, high purity, scalable process for pharmaceutical intermediates and drug discovery.